Resolutions passed at the Annual General Meeting

May 17, 2023

Copenhagen, Denmark, May 17, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), today held its Annual General Meeting, at which the Annual General Meeting.

Company announcement Resolutions passed at the Annual General Meeting

New members of the Board of Directors of Orphazyme

Changes to the Board of Directors

May 17, 2023

Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces that during the Annual General Meeting on May 17, 2023, Bo Jesper Hansen, John Sommer Schmidt and Anders Fink Vadsholt withdrew their candidacy as members of the Board of Directors.

Company announcement Change to Board of Directors

Major shareholder announcement

May 12, 2023

Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S that Scandinavian Investment Group A/S holds shares, corresponding to more than 5% of the total share capital and voting rights in the Company.

Major shareholder announcement

Major shareholder announcement

May 9, 2023

Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Nordic Compound Invest A/S that Nordic Compound Invest A/S holds shares, corresponding to more than 5% of the total share capital and voting rights in the Company.

Major shareholder announcement

Major shareholder announcement

May 9, 2023

Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from MH Investment ApS, that as of May 8, 2023, MH Investment ApS holds shares, corresponding to more than 5% of the total share capital and voting rights in the Company.

Major shareholder announcement

Notice to convene Annual General Meeting

Apr 25, 2023

Orphazyme A/S (ORPHA.CO) (the “Company”), today announces the notice to convene the Company’s Annual General Meeting to be held on: Wednesday, May 17, 2023 at 11:00 AM (CEST) at the offices of Gorrissen Federspiel, Axeltorv 2, DK-1609 Copenhagen V.

Notice to Convene AGM 2023

Appendix 1 Candidates for the Board of Directors

Announcement Notice to convene AGM 2023

Orphazyme Announces Publication of 2022 Financial Results and Annual Report

Apr 25, 2023

Orphazyme A/S (ORPHA.CO) (“Orphazyme” or the “Company”), today announced its financial results for the period from January 1, 2022, to December 31, 2022, and publishes its Annual Report.

Announcement Annual Report 2022

Annual Report 2022

Change to Financial Calendar for 2023 and update regarding class action lawsuit in United States

Apr 17, 2023

Orphazyme A/S (ORPHA.CO) (“Orphazyme” or the “Company”), announces that publication of its financial results for the full year ending December 31, 2022, previously expected April 19, 2023, are now expected to be published on April 25, 2023. Additional time is required to conclude the presentation of the financial statements. The updated financial calendar for 2023 is available on the Company’s website.

Update of RA release date